bioAffinity Technologies, Inc. Stock
Equities
BIAF
US09076W1099
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.87 USD | -6.03% | -10.10% | +27.17% |
Financials (USD)
Sales 2022 | 0 | Sales 2023 | 2.53 | Capitalization | 13.97M |
---|---|---|---|---|---|
Net income 2022 | -8M | Net income 2023 | -7M | EV / Sales 2022 | 464,207,162 x |
Net cash position 2022 | 11.16M | Net cash position 2023 | 1.24M | EV / Sales 2023 | 5,026,702 x |
P/E ratio 2022 |
-0.88
x | P/E ratio 2023 |
-1.62
x | Employees | 14 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.96% |
Latest transcript on bioAffinity Technologies, Inc.
1 day | -6.03% | ||
1 week | -10.10% | ||
Current month | -23.67% | ||
1 month | -20.76% | ||
3 months | +21.43% | ||
6 months | +29.77% | ||
Current year | +27.17% |
Managers | Title | Age | Since |
---|---|---|---|
Maria Zannes
FOU | Founder | 68 | 14-03-25 |
Director of Finance/CFO | 45 | 23-04-30 | |
David Elzi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Girgenti
CHM | Chairman | 78 | 14-02-28 |
Peter Knight
BRD | Director/Board Member | 73 | 18-04-30 |
Stuart Diamond
BRD | Director/Board Member | 63 | 21-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 1.87 | -6.03% | 191,317 |
24-05-13 | 1.99 | -0.50% | 98,417 |
24-05-10 | 2 | -0.99% | 81,821 |
24-05-09 | 2.02 | -2.42% | 103,011 |
24-05-08 | 2.07 | -0.48% | 43,641 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.17% | 22.91M | |
-1.52% | 8.37B | |
+10.68% | 5.84B | |
+26.94% | 5.4B | |
-5.09% | 4.37B | |
-52.54% | 3.23B | |
+14.18% | 2.8B | |
+32.50% | 2.26B | |
-6.47% | 2.22B | |
-1.69% | 1.87B |
- Stock Market
- Equities
- BIAF Stock